BioXcel Therapeutics (BTAI) Return on Sales (2022 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Return on Sales of 0.69% for Q1 2026, up 13.0% year-over-year from 0.61% in Q1 2025, and down 150.02% quarter-over-quarter from 0.28% in Q4 2025.
BioXcel Therapeutics (BTAI) Return on Sales (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Return on Sales history runs 5 years deep, the most recent figure standing at 0.69% for Q1 2026.
- In Q1 2026, Return on Sales rose 13.0% year-over-year to 0.69%; the TTM figure through Mar 2026 stood at 0.87% (down 55.0% YoY), while the FY2025 annual figure was 1.03%, up 10.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.69%, down from 0.28% in the prior quarter.
- The five-year high for Return on Sales was 0.18% in Q2 2024, with the low at 7.13% in Q4 2022.
- The 5-year median for Return on Sales is 0.86% (2024), against an average of 1.73%.
- The sharpest annual moves came in 2023 and 2025: Return on Sales soared 658 bps in 2023, then tumbled 147 bps in 2025.
- BioXcel Therapeutics' Return on Sales stood at 7.13% in 2022, then surged by 92 bps to 0.56% in 2023, then surged by 65 bps to 0.2% in 2024, then plunged by 39 bps to 0.28% in 2025, then slumped by 150 bps to 0.69% in 2026.
- Business Quant data shows BTAI's Return on Sales at 0.69% in Q1 2026, 0.28% in Q4 2025, and 1.83% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 | -0.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.79% |
| Mar 31, 2026 | -0.69% |
| Dec 31, 2025 | -0.28% |
| Sep 30, 2025 | -1.83% |
| Jun 30, 2025 | -1.65% |
| Mar 31, 2025 | -0.82% |
| Dec 31, 2024 | -0.20% |
| Sep 30, 2024 | -0.86% |
| Jun 30, 2024 | -0.18% |
| Mar 31, 2024 | -0.46% |
| Dec 31, 2023 | -0.56% |
| Sep 30, 2023 | -1.60% |
| Jun 30, 2023 | -1.31% |
| Mar 31, 2023 | -4.14% |
| Dec 31, 2022 | -7.13% |
| Sep 30, 2022 | -4.27% |